Samuel Bourassa-Blanchette, Marit M Biesheuvel, John C Lam, Alexander Kipp, Deirdre Church, Julie Carson, Bruce Dalton, Michael D Parkins, Herman W Barkema, Daniel B Gregson
{"title":"念珠菌治疗通过传染病咨询得到改善:一项基于人群的队列研究。","authors":"Samuel Bourassa-Blanchette, Marit M Biesheuvel, John C Lam, Alexander Kipp, Deirdre Church, Julie Carson, Bruce Dalton, Michael D Parkins, Herman W Barkema, Daniel B Gregson","doi":"10.3138/jammi-2024-0001","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Candidemia is a common bloodstream infection with morbidity and mortality. Both the European Society of Clinical Microbiology and Infectious Diseases and Infectious Diseases Society of America have evidence-based recommendations for its management. While infectious diseases consultation (IDC) reduced mortality, effects on guideline concordance remain unclear.</p><p><strong>Methods: </strong>We conducted a multicentre retrospective cohort study (2010-2018) in Canada to characterize the role of IDC in attaining evidence-based recommendations for adults with candidemia. Such recommendations include follow-up blood cultures to document blood clearance, prompt antifungal initiation and selection, source control, treatment duration determination, and ancillary investigations. We measured associations between IDC and adherence to evidence-based recommendations.</p><p><strong>Results: </strong>Patients with candidemia who received IDC were more likely not to be left without antifungal therapy (26% versus 4.8%). Echocardiograms were more common in noncritically ill patients with IDC (64% versus 44%; <i>P</i> < 0.01) and in all critically ill patients, irrespective of IDC status (75% versus 63%; <i>P</i> = 0.08). In patients with uncomplicated candidemia, treatment duration ≥14 days was similar with or without IDC (78% versus 70%; <i>P</i> = 0.15). Patients with complicated candidemia and IDC were more likely treated for ≥42 days (an appropriate duration; 100% versus 47%; <i>P</i> = 0.06). Fluconazole (transition therapy) was not affected by IDC for critically ill (41% and 29%; <i>P</i> = 0.34) or noncritically ill patients (34% versus 24%; <i>P</i> = 0.51). Mortality rates at 30 and 60 days after candidemia diagnosis were lower in patients receiving IDC (<i>P</i> < 0.05).</p><p><strong>Conclusions: </strong>Best practice guidelines were issued for patients with candidemia; adherence varied, but involvement of an infectious disease physician increased implementation and was associated with considerably decreased mortality.</p>","PeriodicalId":36782,"journal":{"name":"JAMMI","volume":"9 3","pages":"129-139"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12169430/pdf/","citationCount":"0","resultStr":"{\"title\":\"Candidemia Treatment is Improved by Infectious Disease Consultation: A Population-Based Cohort Study.\",\"authors\":\"Samuel Bourassa-Blanchette, Marit M Biesheuvel, John C Lam, Alexander Kipp, Deirdre Church, Julie Carson, Bruce Dalton, Michael D Parkins, Herman W Barkema, Daniel B Gregson\",\"doi\":\"10.3138/jammi-2024-0001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Candidemia is a common bloodstream infection with morbidity and mortality. Both the European Society of Clinical Microbiology and Infectious Diseases and Infectious Diseases Society of America have evidence-based recommendations for its management. While infectious diseases consultation (IDC) reduced mortality, effects on guideline concordance remain unclear.</p><p><strong>Methods: </strong>We conducted a multicentre retrospective cohort study (2010-2018) in Canada to characterize the role of IDC in attaining evidence-based recommendations for adults with candidemia. Such recommendations include follow-up blood cultures to document blood clearance, prompt antifungal initiation and selection, source control, treatment duration determination, and ancillary investigations. We measured associations between IDC and adherence to evidence-based recommendations.</p><p><strong>Results: </strong>Patients with candidemia who received IDC were more likely not to be left without antifungal therapy (26% versus 4.8%). Echocardiograms were more common in noncritically ill patients with IDC (64% versus 44%; <i>P</i> < 0.01) and in all critically ill patients, irrespective of IDC status (75% versus 63%; <i>P</i> = 0.08). In patients with uncomplicated candidemia, treatment duration ≥14 days was similar with or without IDC (78% versus 70%; <i>P</i> = 0.15). Patients with complicated candidemia and IDC were more likely treated for ≥42 days (an appropriate duration; 100% versus 47%; <i>P</i> = 0.06). Fluconazole (transition therapy) was not affected by IDC for critically ill (41% and 29%; <i>P</i> = 0.34) or noncritically ill patients (34% versus 24%; <i>P</i> = 0.51). Mortality rates at 30 and 60 days after candidemia diagnosis were lower in patients receiving IDC (<i>P</i> < 0.05).</p><p><strong>Conclusions: </strong>Best practice guidelines were issued for patients with candidemia; adherence varied, but involvement of an infectious disease physician increased implementation and was associated with considerably decreased mortality.</p>\",\"PeriodicalId\":36782,\"journal\":{\"name\":\"JAMMI\",\"volume\":\"9 3\",\"pages\":\"129-139\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12169430/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JAMMI\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3138/jammi-2024-0001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMMI","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3138/jammi-2024-0001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
念珠菌是一种常见的血液感染,发病率和死亡率都很高。欧洲临床微生物学和传染病学会和美国传染病学会都对其管理提出了基于证据的建议。虽然传染病咨询(IDC)降低了死亡率,但对指南一致性的影响仍不清楚。方法:我们在加拿大进行了一项多中心回顾性队列研究(2010-2018),以描述IDC在获得成人念珠菌病循证建议中的作用。这些建议包括随访血培养以记录血液清除率,及时启动和选择抗真菌药物,源头控制,治疗时间确定和辅助调查。我们测量了IDC与循证建议依从性之间的关联。结果:接受IDC治疗的念珠菌病患者更有可能不接受抗真菌治疗(26%对4.8%)。超声心动图在非危重症IDC患者中更为常见(64%对44%;P < 0.01),在所有危重患者中,与IDC状态无关(75%对63%;P = 0.08)。在无并发症念珠菌病患者中,采用或不采用IDC的治疗时间≥14天相似(78% vs 70%;P = 0.15)。合并念珠菌血症和IDC的患者更有可能治疗≥42天(适当的持续时间;100% vs 47%;P = 0.06)。氟康唑(过渡治疗)对危重患者的IDC不受影响(41%和29%;P = 0.34)或非危重症患者(34%对24%;P = 0.51)。IDC组患者在诊断念珠菌后30和60天的死亡率较低(P < 0.05)。结论:针对念珠菌患者发布了最佳实践指南;依从性各不相同,但传染病医生的参与增加了实施,并显著降低了死亡率。
Candidemia Treatment is Improved by Infectious Disease Consultation: A Population-Based Cohort Study.
Introduction: Candidemia is a common bloodstream infection with morbidity and mortality. Both the European Society of Clinical Microbiology and Infectious Diseases and Infectious Diseases Society of America have evidence-based recommendations for its management. While infectious diseases consultation (IDC) reduced mortality, effects on guideline concordance remain unclear.
Methods: We conducted a multicentre retrospective cohort study (2010-2018) in Canada to characterize the role of IDC in attaining evidence-based recommendations for adults with candidemia. Such recommendations include follow-up blood cultures to document blood clearance, prompt antifungal initiation and selection, source control, treatment duration determination, and ancillary investigations. We measured associations between IDC and adherence to evidence-based recommendations.
Results: Patients with candidemia who received IDC were more likely not to be left without antifungal therapy (26% versus 4.8%). Echocardiograms were more common in noncritically ill patients with IDC (64% versus 44%; P < 0.01) and in all critically ill patients, irrespective of IDC status (75% versus 63%; P = 0.08). In patients with uncomplicated candidemia, treatment duration ≥14 days was similar with or without IDC (78% versus 70%; P = 0.15). Patients with complicated candidemia and IDC were more likely treated for ≥42 days (an appropriate duration; 100% versus 47%; P = 0.06). Fluconazole (transition therapy) was not affected by IDC for critically ill (41% and 29%; P = 0.34) or noncritically ill patients (34% versus 24%; P = 0.51). Mortality rates at 30 and 60 days after candidemia diagnosis were lower in patients receiving IDC (P < 0.05).
Conclusions: Best practice guidelines were issued for patients with candidemia; adherence varied, but involvement of an infectious disease physician increased implementation and was associated with considerably decreased mortality.